Objective:
To track how AML-associated mutations and mutated blood-cell populations change before diagnosis, and assess whether these patterns distinguish people who later develop AML.
Approach:
- Longitudinal samples: Researchers analyzed annual blood samples from 47 women who later developed AML and 46 age-matched controls who remained free of blood cancer.
- Mutation tracking: Using TETRIS-seq, the team tracked AML-associated mutations and changes in the size of blood-cell populations carrying them.
- Risk analysis: The researchers also analyzed UK Biobank data to assess whether extensive expansion of mutated cell populations was associated with myeloid leukemia.
Key Findings:
- In about two-thirds of participants who developed AML, the first cancer-associated mutation was estimated to have appeared before age 20.
- Mutated cell populations initially grew slowly; their growth accelerated as additional mutations accumulated, sometimes decades before clinical diagnosis.
- Age-related mutations occurred in both groups, but future AML cases showed more extensive expansion and competition among mutated cell populations.
- UK Biobank analysis found substantially increased odds of myeloid leukemia among individuals with evidence of extensive expansion of a mutated cell population.
Interpretation:
The findings suggest that assessing the extent of mutated-cell expansion, in addition to identifying mutations, may improve molecular risk assessment. The study does not establish a screening test.
Limitations:
- The cohort was relatively small and consisted of older women.
- About one-fifth of AML cases showed little detectable warning before diagnosis.
- Further validation is needed to determine whether monitoring these changes can reliably identify high-risk individuals or guide preventive intervention.
Conclusion:
The study describes AML-associated genetic changes that can begin decades before diagnosis, while noting that the findings require further validation.
Sources:
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
Newsletters
Receive the latest pathologist news, personalities, education, and career development – weekly to your inbox.
